ConductScience.org, home

Paper3479985

Bone-derived and recombinant transforming growth factor beta's are potent inhibitors of tumor cell growth.

Ranchalis JE and 6 others. Biochem Biophys Res Commun, 1987. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Bone-derived and recombinant transforming growth factor beta's are potent inhibitors of tumor cell growth. Papers, record 3479985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3479985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bone-derived and recombinant transforming growth factor beta's are potent inhibitors of tumor cell growth.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
1987
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
1.28
iCite
Revised in PubMed
2019-06-12
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ranchalis JEJ E
2Gentry LL
3Ogawa YY
4Seyedin SMS M
5McPherson JJ
6Purchio AA
7Twardzik DRD R

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone and BonesMajor topic
Growth SubstancesMajor topic
PeptidesMajor topic
Recombinant ProteinsMajor topic
Animals
Cell Line
Cell Survival
Drug Screening Assays, Antitumor
Humans
Transforming Growth Factors

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
9673234Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs.Infect Immun1998https://conductscience.org/library/papers/9673234PubMed
9488418Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.Infect Immun1998https://conductscience.org/library/papers/9488418PubMed
7682701Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/7682701PubMed
7520475Transforming growth factor beta 1 is an inducer of erythroid differentiation.J Exp Med1994https://conductscience.org/library/papers/7520475PubMed
1908509Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).J Exp Med1991https://conductscience.org/library/papers/1908509PubMed
1846264Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro.Am J Pathol1991https://conductscience.org/library/papers/1846264PubMed
1718163Serum response heterogeneity among nonsmall cell lung cancer cell lines.Am J Pathol1991https://conductscience.org/library/papers/1718163PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3479985

GET https://conductscience.org/api/papers/v1/3479985/authors